Use of next-generation sequencing in the CHAT study (acute HCV in HIV): effect of baseline resistance-associated NS3 variants on treatment failure. (2018)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/15284336.2018.1439714

PubMed Identifier: 29493385

Publication URI: http://europepmc.org/abstract/MED/29493385

Type: Journal Article/Review

Volume: 19

Parent Publication: HIV clinical trials

Issue: 2

ISSN: 1528-4336